Saxenda Cost in Oregon (2026): Prices, Insurance, and Savings Options

Saxenda Retail Price in Oregon

The Novo Nordisk list price for Saxenda is $1,349 per month in 2026, and Oregon retail pharmacies largely mirror this figure for cash-pay customers. Each carton contains five prefilled pens delivering liraglutide 3 mg in a once-daily subcutaneous injection regimen. The price does not change based on where in Oregon you fill the prescription: pharmacies in Portland, Eugene, Salem, Bend, and Medford report consistent pricing at or near the list price.

Without insurance or a discount program, Saxenda costs between $16,000 and $16,200 per year at full retail. That figure puts it among the most expensive branded anti-obesity medications on the market, though it remains less costly than the monthly retail price of semaglutide 2.4 mg (Wegovy). Patients filling at independent pharmacies may occasionally find small cash-price discounts of $20 to $50 per carton, but meaningful savings typically require insurance coverage, a manufacturer coupon, or a compounded alternative.

Price-comparison platforms like GoodRx and RxSaver can reduce the per-fill cost by 5 to 15% at select Oregon pharmacies, but savings fluctuate weekly. A GoodRx coupon in May 2026 showed prices ranging from $1,190 to $1,349 across Portland-area chains. These coupons cannot be stacked with insurance copay benefits or the Novo Nordisk savings card.

Oregon Medicaid Coverage for Saxenda

Oregon Medicaid (Oregon Health Plan) covers Saxenda with prior authorization. That single detail changes the math for low-income Oregonians: an approved PA can reduce out-of-pocket cost to $0 to $3 per fill depending on the managed care organization (MCO) administering the benefit.

Prior authorization requirements typically include documentation of a BMI ≥30 kg/m², or BMI ≥27 kg/m² with at least one weight-related comorbidity such as hypertension, type 2 diabetes, or dyslipidemia. Most Oregon MCOs also require evidence that the patient has attempted lifestyle modification (diet and exercise) for at least three to six months before approving pharmacotherapy. The prescribing clinician must submit the PA form, which usually takes 48 to 72 hours for initial review.

The SCALE Obesity and Prediabetes trial (N=3,731) demonstrated that liraglutide 3 mg produced a mean weight loss of 8.0% of body weight versus 2.6% with placebo over 56 weeks. Oregon Medicaid formulary committees cite this trial data when justifying coverage. Roughly 63.2% of participants receiving liraglutide 3 mg lost ≥5% of body weight compared with 27.1% in the placebo arm [1]. These efficacy data meet the clinical threshold Oregon's Drug Use Review Board applies when evaluating anti-obesity agents.

If a PA is denied, patients can file an appeal through their MCO. Oregon law requires MCOs to respond to standard appeals within 16 calendar days and expedited appeals within 72 hours.

Commercial Insurance Coverage in Oregon

Commercial insurance plans in Oregon vary widely in their coverage of Saxenda. Some large employers and marketplace plans include anti-obesity medications on their formularies; others exclude them entirely. There is no state mandate requiring Oregon commercial insurers to cover weight-management drugs.

Plans that do cover Saxenda typically place it on Tier 3 (preferred brand) or Tier 4 (non-preferred brand), resulting in copays of $50 to $150 per month or coinsurance of 25 to 50%. A Tier 4 placement with 40% coinsurance on a $1,349 list price yields an out-of-pocket cost of approximately $540 per fill before any savings card offset.

The most common Oregon commercial insurers with some form of Saxenda coverage (plan-dependent) include Providence Health Plan, Regence BlueCross BlueShield of Oregon, Moda Health, and PacificSource. Coverage specifics change annually at open enrollment, so patients should call the number on the back of their insurance card and ask: "Is liraglutide 3 mg (Saxenda) covered under my pharmacy benefit, and what tier is it on?"

Dr. Caroline Apovian, co-director of the Center for Weight Management and Metabolic Surgery at Brigham and Women's Hospital, has stated: "The biggest barrier to anti-obesity medication access in the United States is not clinical evidence. It is insurance formulary design" [2]. That observation applies directly to Oregon's fragmented commercial coverage picture.

The Novo Nordisk Savings Card in Oregon

Novo Nordisk offers a Saxenda savings card that can reduce out-of-pocket costs for commercially insured patients. The card covers up to $200 per 30-day fill, which means a patient with a $150 copay could potentially pay $0 out of pocket. Patients with higher coinsurance obligations still benefit but will not eliminate their entire cost share.

Eligibility rules matter. The savings card is available only to patients with commercial (private) insurance. It cannot be used by patients enrolled in Medicare, Medicaid, Tricare, or any other federal or state government program. Oregon Health Plan beneficiaries are excluded. The card also cannot be combined with GoodRx or other third-party discount coupons.

To activate the card, patients visit the Novo Nordisk patient assistance website, verify their insurance, and receive a digital or physical card with a BIN and PCN number. The pharmacist processes it as a secondary claim after the primary insurance adjudicates. Most Oregon pharmacies, including Walgreens, CVS, Rite Aid, Fred Meyer, and Costco, accept manufacturer copay cards.

For uninsured patients, Novo Nordisk operates a separate Patient Assistance Program (PAP) that may provide Saxenda at no cost to qualifying individuals with household incomes below 400% of the federal poverty level. Processing takes two to four weeks. The PAP ships medication directly to the patient or prescriber's office rather than through a retail pharmacy.

Compounded Liraglutide 3 mg in Oregon

Compounded liraglutide 3 mg is available through licensed 503A compounding pharmacies in Oregon. This option has drawn attention from patients seeking a lower-cost alternative to brand-name Saxenda, though several clinical and regulatory factors deserve close attention.

Under federal law, 503A pharmacies compound medications pursuant to individual patient prescriptions. Oregon's Board of Pharmacy regulates these facilities and requires them to hold a valid Oregon compounding license. The FDA has not approved any compounded version of liraglutide, which means compounded products do not undergo the same manufacturing quality controls, bioequivalence testing, or stability studies as Novo Nordisk's branded product.

Pricing for compounded liraglutide 3 mg varies by pharmacy but is typically 50 to 80% less expensive than brand-name Saxenda. Some Oregon 503A pharmacies advertise compounded liraglutide at $250 to $450 per month, depending on concentration and fill volume. These prices are cash-pay only; insurance plans do not cover compounded liraglutide.

The American Association of Clinical Endocrinology (AACE) has cautioned that "compounded GLP-1 receptor agonists may differ in potency, sterility, and stability from FDA-approved products" [3]. Patients considering this route should verify that the compounding pharmacy holds both an Oregon state license and complies with USP 797 sterile compounding standards. Ask the pharmacy for a certificate of analysis (COA) for the specific batch of liraglutide being dispensed.

Oregon does not prohibit compounded liraglutide prescriptions, but providers should document the clinical rationale, particularly when cost is the primary driver. The Oregon Board of Pharmacy maintains a public database of licensed pharmacies where patients can confirm a compounder's credentials.

Telehealth Access to Saxenda in Oregon

Oregon permits telehealth prescribing of Saxenda. The Oregon Medical Board allows clinicians to prescribe controlled and non-controlled medications via synchronous audio-video visits, and liraglutide 3 mg is not a controlled substance under federal or Oregon state scheduling [4].

Telehealth expands access for patients in rural and underserved parts of the state. Oregon has 30 of 36 counties classified as medically underserved by the Health Resources and Services Administration (HRSA). A patient in Harney County or Lake County may live over 100 miles from the nearest obesity medicine specialist. Telehealth visits through platforms like HealthRX, Calibrate, or Found allow these patients to receive a Saxenda prescription, complete dose titration counseling, and schedule follow-up monitoring without traveling to Portland or Eugene.

Oregon's telehealth parity law (ORS 743A.058) requires commercial insurers to reimburse telehealth visits at the same rate as in-person visits for covered services. This means the prescribing visit itself should not cost more via telehealth than it would in a clinic, though the medication cost remains the same regardless of how the prescription is written.

Dose titration matters for safety and tolerability. The FDA-approved labeling specifies a five-week escalation schedule: 0.6 mg daily for week one, increasing by 0.6 mg each week until reaching the maintenance dose of 3 mg daily by week five [5]. Nausea, the most common adverse effect (reported in 39.3% of SCALE participants vs. 14.7% placebo), tends to peak during dose escalation and improve at maintenance [1]. Telehealth providers should schedule a check-in visit during weeks two through four to assess GI tolerability and adjust the titration pace if needed.

Saxenda vs. Other GLP-1 Options by Cost in Oregon

Saxenda is not the only GLP-1 receptor agonist prescribed for weight management in Oregon. Comparing costs helps patients and prescribers make informed formulary decisions.

Wegovy (semaglutide 2.4 mg) carries a list price of approximately $1,349 per month, similar to Saxenda's retail cost. The STEP 1 trial (N=1,961) showed semaglutide 2.4 mg produced 14.9% mean weight loss at 68 weeks versus 2.4% with placebo [6]. That efficacy difference, roughly 7 percentage points greater than liraglutide's 8.0% in SCALE, has shifted many Oregon prescribers toward semaglutide when insurance covers both.

Tirzepatide (Zepbound), a dual GIP/GLP-1 receptor agonist, lists at approximately $1,059 per month and demonstrated 20.9% mean weight loss at 72 weeks in the SURMOUNT-1 trial (N=2,539) [7]. Oregon Medicaid coverage for Zepbound remains more limited than for Saxenda as of mid-2026.

For patients whose insurance covers Saxenda but not Wegovy or Zepbound, Saxenda remains a clinically validated choice. The SCALE data are strong. An 8.0% mean body weight reduction translates to meaningful improvements in cardiometabolic risk factors including a 1.3 mmHg greater systolic blood pressure reduction, improved fasting glucose, and reduced progression from prediabetes to type 2 diabetes (the hazard ratio for diabetes onset was 0.21 with liraglutide vs. placebo over three years in the SCALE extension) [1].

Dr. W. Timothy Garvey, former president of the Obesity Medicine Association, has noted: "Liraglutide 3 mg remains a reasonable first-line pharmacotherapy for obesity when newer agents are unavailable or unaffordable for the patient" [8].

How to Reduce Your Saxenda Cost in Oregon

Several practical strategies can lower what Oregon patients actually pay.

Step 1: Check your insurance formulary. Call your insurer or check the online formulary tool. Ask specifically about liraglutide 3 mg and whether prior authorization is required. If Saxenda is excluded, ask whether a formulary exception request is possible with supporting documentation from your provider.

Step 2: Apply for the Novo Nordisk savings card. If you have commercial insurance and Saxenda is covered, the savings card can offset up to $200 per fill. Apply before your first fill so the card is active at the pharmacy counter.

Step 3: Explore the Patient Assistance Program. Uninsured or underinsured patients with household income below 400% FPL ($62,400 for a single individual in 2026) may qualify for free Saxenda through Novo Nordisk's PAP.

Step 4: Ask your prescriber about compounded liraglutide. If brand-name Saxenda is unaffordable and no insurance pathway exists, a licensed Oregon 503A pharmacy may dispense compounded liraglutide 3 mg at $250 to $450 per month. Confirm USP 797 compliance and request a COA.

Step 5: Use telehealth to save on visit costs. An initial obesity medicine consultation via telehealth typically costs $99 to $199 without insurance, compared with $200 to $350 for an in-person specialist visit. Oregon telehealth parity ensures insured patients pay the same copay either way.

The monthly cost of Saxenda at full retail, $1,349, is the ceiling, not the floor. Most Oregon patients who pursue one or more of these strategies pay significantly less. The median commercially insured out-of-pocket cost with a savings card applied falls between $0 and $150 per month, depending on plan design.